Literature DB >> 33468484

In Vitro Study of the Synergistic Effect of an Enzyme Cocktail and Antibiotics against Biofilms in a Prosthetic Joint Infection Model.

Hervé Poilvache1,2,3, Albert Ruiz-Sorribas2, Olivier Cornu1,3, Françoise Van Bambeke4.   

Abstract

Prosthetic joint infections (PJI) are frequent complications of arthroplasties. Their treatment is made complex by the rapid formation of bacterial biofilms, limiting the effectiveness of antibiotic therapy. In this study, we explore the effect of a tri-enzymatic cocktail (TEC) consisting of an endo-1,4-β-d-glucanase, a β-1,6-hexosaminidase, and an RNA/DNA nonspecific endonuclease combined with antibiotics of different classes against biofilms of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli grown on Ti-6Al-4V substrates. Biofilms were grown in Trypticase soy broth (TSB) with 10 g/liter glucose and 20 g/liter NaCl (TGN). Mature biofilms were assigned to a control group or treated with the TEC for 30 min and then either analyzed or reincubated for 24 h in TGN or TGN with antibiotics. The cytotoxicity of the TEC was assayed against MG-63 osteoblasts, primary murine fibroblasts, and J-774 macrophages using the lactate dehydrogenase (LDH) release test. The TEC dispersed 80.3 to 95.2% of the biofilms' biomass after 30 min. The reincubation of the treated biofilms with antibiotics resulted in a synergistic reduction of the total culturable bacterial count (CFU) compared to that of biofilms treated with antibiotics alone in the three tested species (additional reduction from 2 to more than 3 log10 CFU). No toxicity of the TEC was observed against the tested cell lines after 24 h of incubation. The combination of pretreatment with TEC followed by 24 h of incubation with antibiotics had a synergistic effect against biofilms of S. aureus, S. epidermidis, and E. coli Further studies should assess the potential of the TEC as an adjuvant therapy in in vivo models of PJI.
Copyright © 2021 American Society for Microbiology.

Entities:  

Keywords:  Escherichia coli; Staphylococcus aureus; Staphylococcus epidermidis; antibiotics; biofilms; cellulase; coagulase-negative staphylococci; dispersin B; endonuclease; enzymes; prosthesis infections; prosthetic joint infection

Year:  2021        PMID: 33468484      PMCID: PMC8097427          DOI: 10.1128/AAC.01699-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

1.  The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix.

Authors:  X Zogaj; M Nimtz; M Rohde; W Bokranz; U Römling
Journal:  Mol Microbiol       Date:  2001-03       Impact factor: 3.501

2.  The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms.

Authors:  H Ceri; M E Olson; C Stremick; R R Read; D Morck; A Buret
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Antimicrobial Tolerance in Biofilms.

Authors:  Philip S Stewart
Journal:  Microbiol Spectr       Date:  2015-06

4.  Pulse lavage is inadequate at removal of biofilm from the surface of total knee arthroplasty materials.

Authors:  Kenneth L Urish; Peter W DeMuth; David W Craft; Hani Haider; Charles M Davis
Journal:  J Arthroplasty       Date:  2013-12-16       Impact factor: 4.757

5.  Permeability of rheumatoid and normal human synovium to specific plasma proteins.

Authors:  J R Levick
Journal:  Arthritis Rheum       Date:  1981-12

6.  Economic burden of periprosthetic joint infection in the United States.

Authors:  Steven M Kurtz; Edmund Lau; Heather Watson; Jordana K Schmier; Javad Parvizi
Journal:  J Arthroplasty       Date:  2012-05-02       Impact factor: 4.757

Review 7.  Novel Treatment Strategies for Biofilm-Based Infections.

Authors:  Claudia Vuotto; Gianfranco Donelli
Journal:  Drugs       Date:  2019-10       Impact factor: 9.546

8.  Comparative Epidemiology of Revision Arthroplasty: Failed THA Poses Greater Clinical and Economic Burdens Than Failed TKA.

Authors:  Kevin J Bozic; Atul F Kamath; Kevin Ong; Edmund Lau; Steve Kurtz; Vanessa Chan; Thomas P Vail; Harry Rubash; Daniel J Berry
Journal:  Clin Orthop Relat Res       Date:  2014-12-03       Impact factor: 4.176

9.  Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci.

Authors:  Jeffrey B Kaplan; Karen LoVetri; Silvia T Cardona; Srinivasa Madhyastha; Irina Sadovskaya; Saïd Jabbouri; Era A Izano
Journal:  J Antibiot (Tokyo)       Date:  2011-12-14       Impact factor: 2.649

10.  Orthopaedic device-related infection: current and future interventions for improved prevention and treatment.

Authors:  T Fintan Moriarty; Richard Kuehl; Tom Coenye; Willem-Jan Metsemakers; Mario Morgenstern; Edward M Schwarz; Martijn Riool; Sebastian A J Zaat; Nina Khana; Stephen L Kates; R Geoff Richards
Journal:  EFORT Open Rev       Date:  2017-03-13
View more
  2 in total

1.  Pharmacodynamics of Moxifloxacin, Meropenem, Caspofungin, and Their Combinations against In Vitro Polymicrobial Interkingdom Biofilms.

Authors:  Albert Ruiz-Sorribas; Hervé Poilvache; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2021-12-20       Impact factor: 5.938

2.  Hydrolytic Enzymes as Potentiators of Antimicrobials against an Inter-Kingdom Biofilm Model.

Authors:  Albert Ruiz-Sorribas; Hervé Poilvache; Nur Hidayatul Nazirah Kamarudin; Annabel Braem; Françoise Van Bambeke
Journal:  Microbiol Spectr       Date:  2022-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.